NCT06838546 2025-02-20
A Multicenter, Open Phase IIb Clinical Study to Evaluate the Efficacy and Safety of B1962 Injection in the Treatment of Advanced Colorectal Cancer
Tasly Biopharmaceuticals Co., Ltd.
Phase 2 Not yet recruiting
Tasly Biopharmaceuticals Co., Ltd.
PharmaMar
Eisai Inc.
Taiho Pharmaceutical Co., Ltd.